These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
323 related articles for article (PubMed ID: 31348886)
81. HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogen. Jardine JG; Kulp DW; Havenar-Daughton C; Sarkar A; Briney B; Sok D; Sesterhenn F; Ereño-Orbea J; Kalyuzhniy O; Deresa I; Hu X; Spencer S; Jones M; Georgeson E; Adachi Y; Kubitz M; deCamp AC; Julien JP; Wilson IA; Burton DR; Crotty S; Schief WR Science; 2016 Mar; 351(6280):1458-63. PubMed ID: 27013733 [TBL] [Abstract][Full Text] [Related]
82. Structural insights on the role of antibodies in HIV-1 vaccine and therapy. West AP; Scharf L; Scheid JF; Klein F; Bjorkman PJ; Nussenzweig MC Cell; 2014 Feb; 156(4):633-48. PubMed ID: 24529371 [TBL] [Abstract][Full Text] [Related]
83. Antibody-directed evolution reveals a mechanism for enhanced neutralization at the HIV-1 fusion peptide site. Banach BB; Pletnev S; Olia AS; Xu K; Zhang B; Rawi R; Bylund T; Doria-Rose NA; Nguyen TD; Fahad AS; Lee M; Lin BC; Liu T; Louder MK; Madan B; McKee K; O'Dell S; Sastry M; Schön A; Bui N; Shen CH; Wolfe JR; Chuang GY; Mascola JR; Kwong PD; DeKosky BJ Nat Commun; 2023 Nov; 14(1):7593. PubMed ID: 37989731 [TBL] [Abstract][Full Text] [Related]
84. High throughput analysis of B cell dynamics and neutralizing antibody development during immunization with a novel clade C HIV-1 envelope. Mopuri R; Welbourn S; Charles T; Ralli-Jain P; Rosales D; Burton S; Aftab A; Karunakaran K; Pellegrini K; Kilembe W; Karita E; Gnanakaran S; Upadhyay AA; Bosinger SE; Derdeyn CA PLoS Pathog; 2023 Oct; 19(10):e1011717. PubMed ID: 37878666 [TBL] [Abstract][Full Text] [Related]
85. Broadly neutralizing antibodies present new prospects to counter highly antigenically diverse viruses. Burton DR; Poignard P; Stanfield RL; Wilson IA Science; 2012 Jul; 337(6091):183-6. PubMed ID: 22798606 [TBL] [Abstract][Full Text] [Related]
86. Rapid selection of HIV envelopes that bind to neutralizing antibody B cell lineage members with functional improbable mutations. Swanson O; Rhodes B; Wang A; Xia SM; Parks R; Chen H; Sanzone A; Cooper M; Louder MK; Lin BC; Doria-Rose NA; Bonsignori M; Saunders KO; Wiehe K; Haynes BF; Azoitei ML Cell Rep; 2021 Aug; 36(7):109561. PubMed ID: 34407396 [TBL] [Abstract][Full Text] [Related]
87. Somatic mutations of the immunoglobulin framework are generally required for broad and potent HIV-1 neutralization. Klein F; Diskin R; Scheid JF; Gaebler C; Mouquet H; Georgiev IS; Pancera M; Zhou T; Incesu RB; Fu BZ; Gnanapragasam PN; Oliveira TY; Seaman MS; Kwong PD; Bjorkman PJ; Nussenzweig MC Cell; 2013 Mar; 153(1):126-38. PubMed ID: 23540694 [TBL] [Abstract][Full Text] [Related]
88. Human B-cell ontogeny in humanized NOD/SCID γc(null) mice generates a diverse yet auto/poly- and HIV-1-reactive antibody repertoire. Chang H; Biswas S; Tallarico AS; Sarkis PT; Geng S; Panditrao MM; Zhu Q; Marasco WA Genes Immun; 2012 Jul; 13(5):399-410. PubMed ID: 22592523 [TBL] [Abstract][Full Text] [Related]
89. B-cell-lineage immunogen design in vaccine development with HIV-1 as a case study. Haynes BF; Kelsoe G; Harrison SC; Kepler TB Nat Biotechnol; 2012 May; 30(5):423-33. PubMed ID: 22565972 [TBL] [Abstract][Full Text] [Related]
90. bNAber: database of broadly neutralizing HIV antibodies. Eroshkin AM; LeBlanc A; Weekes D; Post K; Li Z; Rajput A; Butera ST; Burton DR; Godzik A Nucleic Acids Res; 2014 Jan; 42(Database issue):D1133-9. PubMed ID: 24214957 [TBL] [Abstract][Full Text] [Related]
92. HIV-1 Envelope Spike MPER: From a Vaccine Target to a New Druggable Pocket for Novel and Effective Fusion Inhibitors. Luque FJ; Camarasa MJ ChemMedChem; 2021 Jan; 16(1):105-107. PubMed ID: 33428329 [TBL] [Abstract][Full Text] [Related]
93. Frequency-potency analysis of IgG+ memory B cells delineates neutralizing antibody responses at single-cell resolution. Tenggara MK; Oh SH; Yang C; Nariya HK; Metz AM; Upadhyay AA; Gudipati DR; Guo L; McGhee EG; Gill K; Viox EG; Mason RD; Doria-Rose NA; Foulds KE; Mascola JR; Du Y; Fu H; Altman JD; Yan Q; Sheng Z; Bosinger SE; Kong R Cell Rep; 2024 Mar; 43(3):113948. PubMed ID: 38483908 [TBL] [Abstract][Full Text] [Related]
94. Priming antibody responses to the fusion peptide in rhesus macaques. Cottrell CA; Pratap PP; Cirelli KM; Carnathan DG; Enemuo CA; Antanasijevic A; Ozorowski G; Sewall LM; Gao H; Allen JD; Nogal B; Silva M; Bhiman J; Pauthner M; Irvine DJ; Montefiori D; Crispin M; Burton DR; Silvestri G; Crotty S; Ward AB NPJ Vaccines; 2024 Jul; 9(1):126. PubMed ID: 38997302 [TBL] [Abstract][Full Text] [Related]
95. Immune Monitoring Reveals Fusion Peptide Priming to Imprint Cross-Clade HIV-Neutralizing Responses with a Characteristic Early B Cell Signature. Cheng C; Duan H; Xu K; Chuang GY; Corrigan AR; Geng H; O'Dell S; Ou L; Chambers M; Changela A; Chen X; Foulds KE; Sarfo EK; Jafari AJ; Hill KR; Kong R; Liu K; Todd JP; Tsybovsky Y; Verardi R; Wang S; Wang Y; Wu W; Zhou T; ; Arnold FJ; Doria-Rose NA; Koup RA; McDermott AB; Scorpio DG; Worobey M; Shapiro L; Mascola JR; Kwong PD Cell Rep; 2020 Aug; 32(5):107981. PubMed ID: 32755575 [TBL] [Abstract][Full Text] [Related]
96. Preclinical Development of a Fusion Peptide Conjugate as an HIV Vaccine Immunogen. Ou L; Kong WP; Chuang GY; Ghosh M; Gulla K; O'Dell S; Varriale J; Barefoot N; Changela A; Chao CW; Cheng C; Druz A; Kong R; McKee K; Rawi R; Sarfo EK; Schön A; Shaddeau A; Tsybovsky Y; Verardi R; Wang S; Wanninger TG; Xu K; Yang GJ; Zhang B; Zhang Y; Zhou T; ; Arnold FJ; Doria-Rose NA; Lei QP; Ryan ET; Vann WF; Mascola JR; Kwong PD Sci Rep; 2020 Feb; 10(1):3032. PubMed ID: 32080235 [TBL] [Abstract][Full Text] [Related]
97. Recapitulation of HIV-1 Env-antibody coevolution in macaques leading to neutralization breadth. Roark RS; Li H; Williams WB; Chug H; Mason RD; Gorman J; Wang S; Lee FH; Rando J; Bonsignori M; Hwang KK; Saunders KO; Wiehe K; Moody MA; Hraber PT; Wagh K; Giorgi EE; Russell RM; Bibollet-Ruche F; Liu W; Connell J; Smith AG; DeVoto J; Murphy AI; Smith J; Ding W; Zhao C; Chohan N; Okumura M; Rosario C; Ding Y; Lindemuth E; Bauer AM; Bar KJ; Ambrozak D; Chao CW; Chuang GY; Geng H; Lin BC; Louder MK; Nguyen R; Zhang B; Lewis MG; Raymond DD; Doria-Rose NA; Schramm CA; Douek DC; Roederer M; Kepler TB; Kelsoe G; Mascola JR; Kwong PD; Korber BT; Harrison SC; Haynes BF; Hahn BH; Shaw GM Science; 2021 Jan; 371(6525):. PubMed ID: 33214287 [TBL] [Abstract][Full Text] [Related]
98. Development of a 3Mut-Apex-Stabilized Envelope Trimer That Expands HIV-1 Neutralization Breadth When Used To Boost Fusion Peptide-Directed Vaccine-Elicited Responses. Chuang GY; Lai YT; Boyington JC; Cheng C; Geng H; Narpala S; Rawi R; Schmidt SD; Tsybovsky Y; Verardi R; Xu K; Yang Y; Zhang B; Chambers M; Changela A; Corrigan AR; Kong R; Olia AS; Ou L; Sarfo EK; Wang S; Wu W; Doria-Rose NA; McDermott AB; Mascola JR; Kwong PD J Virol; 2020 Jun; 94(13):. PubMed ID: 32295908 [TBL] [Abstract][Full Text] [Related]
99. VRC34-Antibody Lineage Development Reveals How a Required Rare Mutation Shapes the Maturation of a Broad HIV-Neutralizing Lineage. Shen CH; DeKosky BJ; Guo Y; Xu K; Gu Y; Kilam D; Ko SH; Kong R; Liu K; Louder MK; Ou L; Zhang B; Chao CW; Corcoran MM; Feng E; Huang J; Normandin E; O'Dell S; Ransier A; Rawi R; Sastry M; Schmidt SD; Wang S; Wang Y; Chuang GY; Doria-Rose NA; Lin B; Zhou T; Boritz EA; Connors M; Douek DC; Karlsson Hedestam GB; Sheng Z; Shapiro L; Mascola JR; Kwong PD Cell Host Microbe; 2020 Apr; 27(4):531-543.e6. PubMed ID: 32130953 [TBL] [Abstract][Full Text] [Related]